Related Experiment Video
Updated: Aug 19, 2026

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
Mitf regulates osteoclastogenesis by modulating NFATc1 activity
Ssu-Yi Lu1, Mengtao Li2, Yi-Ling Lin3
1Department of Diagnostic and Surgical Sciences, School of Dentistry, University of California, Los Angeles, CA, USA.
Abstract:
Transcription factors Mitf and NFATc1 share many downstream targets that are critical for osteoclastogenesis. Since RANKL signals induce/activate both NFATc1 and Mitf isoform-E (Mitf-E), a tissue-restricted Mitf isoform in osteoclasts, it is plausible that the two factors work together to promote osteoclastogenesis. Although Mitf was shown to function upstream of NFATc1 previously, this study showed that expression of Mitf had little effects on NFATc1 and NFATc1 was critical for the induction of Mitf-E. In Mitf(mi/mi) mice, the semi-dominant mutation in Mitf gene leads to arrest of osteoclastogenesis in the early stages. However, when stimulated by RANKL, the Mitf(mi/mi) preosteoclasts responded with a significant induction of NFATc1, despite that the cells cannot differentiate into functional osteoclasts. In the absence of RANKL stimulation, very high levels of NFATc1 are required to drive osteoclast development. Our data indicate that Mitf functions downstream of NFATc1 in the RANKL pathway, and it plays an important role in amplifying NFATc1-dependent osteoclastogenic signals, which contributes to the significant synergy between the two factors during osteoclastogenesis. We propose that Mitf-E functions as a tissue-specific modulator for events downstream of NFATc1 activation during osteoclastogenesis.
Insights
This study reveals that transcription factor Mitf-E acts downstream of NFATc1 in osteoclastogenesis, amplifying signals for bone cell development. Mitf-E modulates NFATc1 activity, highlighting a synergistic relationship crucial for osteoclast formation.
Area of Science:
- Cell Biology
- Molecular Biology
- Developmental Biology
Background:
- Transcription factors Mitf and NFATc1 are key regulators of osteoclastogenesis.
- RANKL signaling activates both NFATc1 and the osteoclast-specific Mitf-E isoform.
- Previous studies suggested Mitf acts upstream of NFATc1, but this study re-evaluates their relationship.
Purpose of the Study:
- To investigate the functional relationship between Mitf and NFATc1 in osteoclastogenesis.
- To determine the role of Mitf-E in RANKL-induced osteoclast differentiation.
- To elucidate the signaling pathway involving Mitf and NFATc1.
Main Methods:
- Analysis of Mitf(mi/mi) mice with a semi-dominant mutation in the Mitf gene.
- Assessment of NFATc1 induction in preosteoclasts under RANKL stimulation.
- Evaluation of Mitf-E expression and its dependence on NFATc1.
Main Results:
- Mitf expression showed minimal effect on NFATc1 levels.
- NFATc1 was critical for the induction of Mitf-E.
- Mitf(mi/mi) preosteoclasts showed NFATc1 induction upon RANKL stimulation but failed to differentiate.
- Mitf functions downstream of NFATc1, amplifying NFATc1-dependent signals.
Conclusions:
- Mitf acts downstream of NFATc1 in the RANKL pathway, amplifying osteoclastogenic signals.
- Mitf-E serves as a tissue-specific modulator of events downstream of NFATc1 activation.
- A synergistic interaction between Mitf and NFATc1 is essential for osteoclastogenesis.
More Related Videos
07:49Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling
Published on: August 3, 2018
06:41Quantitative Analysis of Mitochondria-Associated Endoplasmic Reticulum Membrane (MAM) Stabilization in a Neural Model of Alzheimer's Disease (AD)
Published on: January 10, 2025
Related Concept Videos
Co-activators and Co-repressors
Master Transcription Regulators
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Osteoclasts in Bone Remodeling
TGF - β Signaling Pathway
NF-kB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...